Abiomed
ABMD
#1257
Rank
S$22.26 B
Marketcap
S$493.76
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Abiomed (ABMD) - Total liabilities

Total liabilities on the balance sheet as of September 2022 : S$0.20 Billion

According to Abiomed's latest financial reports the company's total liabilities are S$0.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Abiomed - Total liabilities on balance sheet (from 2013 to 2022)

Total liabilities by year

Year Total liabilities Change
2022-03-31S$0.23 B3.98%
2021-03-31S$0.22 B3.18%
2020-03-31S$0.21 B34.96%
2019-03-31S$0.15 B25.25%
2018-03-31S$0.12 B-7.53%
2017-03-31S$0.13 B84.68%
2016-03-31S$74.36 M15.69%
2015-03-31S$64.27 M37.85%
2014-03-31S$46.62 M14.13%
2013-03-31S$40.85 M17.73%
2012-03-31S$34.7 M2.59%
2011-03-31S$33.82 M12.01%
2010-03-31S$30.2 M-0.46%
2009-03-31S$30.34 M-9.97%
2008-03-31S$33.7 M57.69%
2007-03-31S$21.37 M45.14%
2006-03-31S$14.72 M81.89%
2005-03-31S$8.09 M0.44%
2004-03-31S$8.06 M-26.92%
2003-03-31S$11.03 M-41.42%
2002-03-31S$18.83 M11.12%
2001-03-31S$16.94 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Teleflex
TFX
S$5.24 B 2,483.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
S$24.72 B 12,069.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
S$0.20 B 1.39%๐Ÿ‡บ๐Ÿ‡ธ USA